Home › Funds › Spruce Street Capital LP › ALEC
Spruce Street Capital LP position in ALEC
ALECTOR INC · Health Care
Spruce Street Capital LP reported holding 2,101,068 shares of ALEC (ALECTOR INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 0.62% of its reported portfolio and ranking #32 among its reported holdings. Spruce Street Capital LP has disclosed ALEC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's ALEC position evolved
Spruce Street Capital LP first disclosed a stake in ALEC in Q4 2025 at 1,117,986 shares (US$1.7M). The position peaked in Q1 2026 at 2,101,068 shares, worth US$4.5M. Across 4 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,101,068 shares valued at US$3.9M. Notable position changes include a 88% increase in Q1 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.12M | $1.74M | New |
| Q1 2026 | 2.10M | $4.52M | Add |
| Q2 2026 | 2.10M | $4.22M | Hold |
| Q3 2026 | 2.10M | $3.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALEC and 13F data
ALEC (ALECTOR INC) is a Health Care company. 27 other funds we track also report a position in ALEC — the largest reported positions include TCG Crossover Management, LLC (US$20.1M), Kynam Capital Management, LP (US$7.7M), Merck & Co., Inc. (US$6.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALEC
- TCG Crossover Management, LLC 10.00M sh · $20.10M · Q2 2026
- Kynam Capital Management, LP 3.81M sh · $7.66M · Q2 2026
- Merck & Co., Inc. 3.55M sh · $6.56M · Q3 2026
- Ikarian Capital, LLC 1.98M sh · $3.99M · Q2 2026
- MEDICI CAPITAL LLC 1.65M sh · $3.06M · Q3 2026
- Euclidean Capital LLC 1.31M sh · $2.63M · Q2 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held ALEC?
Spruce Street Capital LP has disclosed ALEC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in ALEC?
As of Q3 2026, Spruce Street Capital LP holds 2.10M shares of ALEC (ALECTOR INC), valued at $3.89M, representing 0.62% of its reported portfolio and ranking #32.
Has Spruce Street Capital LP been buying or selling ALEC?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in ALEC. The position peaked in Q1 2026 at 2.10M shares.
Which other funds hold ALEC?
Other major institutional holders of ALEC include TCG Crossover Management, LLC, Kynam Capital Management, LP, Merck & Co., Inc., among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.